We are live on ! Find out more
CP

Covenant Partners Portfolio holdings

AUM $342M
1-Year Est. Return 19.24%
This Fund
S&P 500
This Quarter Est. Return
+7.01%
1 Year Est. Return
+19.24%
3 Year Est. Return
+70.32%
5 Year Est. Return
+79.29%
10 Year Est. Return
AUM
$353M
AUM Growth
+$17.7M
Cap. Flow
-$3.98M
Cap. Flow %
-1.13%
Top 10 Hldgs %
75.02%
Holding
150
New
4
Increased
17
Reduced
12
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 8.55%
2 Financials 5.97%
3 Healthcare 3.24%
4 Consumer Discretionary 3.24%
5 Industrials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
51
AstraZeneca
AZN
$263B
$709K 0.2%
4,623
TSLA icon
52
Tesla
TSLA
$1.24T
$708K 0.2%
1,591
-1,313
-45% -$455K
ZTS icon
53
Zoetis
ZTS
$31.6B
$707K 0.2%
4,834
NEE icon
54
NextEra Energy
NEE
$187B
$691K 0.2%
9,147
PGR icon
55
Progressive
PGR
$124B
$661K 0.19%
2,678
SNPS icon
56
Synopsys
SNPS
$71.5B
$651K 0.18%
1,320
TMO icon
57
Thermo Fisher Scientific
TMO
$211B
$645K 0.18%
1,329
BRK.B icon
58
Berkshire Hathaway Class B
BRK.B
$1.07T
$642K 0.18%
1,277
+91
+8% +$44.1K
RYAAY icon
59
Ryanair
RYAAY
$29.5B
$642K 0.18%
10,655
ISRG icon
60
Intuitive Surgical
ISRG
$121B
$624K 0.18%
1,396
SMFG icon
61
Sumitomo Mitsui Financial
SMFG
$166B
$624K 0.18%
37,262
MELI icon
62
Mercado Libre
MELI
$91.3B
$587K 0.17%
251
TJX icon
63
TJX Companies
TJX
$170B
$583K 0.17%
4,034
CSX icon
64
CSX Corp
CSX
$98.6B
$564K 0.16%
15,885
IVV icon
65
iShares Core S&P 500 ETF
IVV
$876B
$560K 0.16%
837
+29
+4% +$18.7K
PG icon
66
Procter & Gamble
PG
$343B
$549K 0.16%
3,571
EME icon
67
Emcor
EME
$33.1B
$547K 0.16%
842
PLTR icon
68
Palantir
PLTR
$295B
$544K 0.15%
2,983
EQIX icon
69
Equinix
EQIX
$107B
$500K 0.14%
638
UBER icon
70
Uber
UBER
$134B
$478K 0.14%
4,880
CRM icon
71
Salesforce
CRM
$134B
$474K 0.13%
2,001
LIN icon
72
Linde
LIN
$237B
$465K 0.13%
979
MT icon
73
ArcelorMittal
MT
$50.4B
$464K 0.13%
12,834
CW icon
74
Curtiss-Wright
CW
$27.7B
$461K 0.13%
850
RMD icon
75
ResMed
RMD
$28.3B
$456K 0.13%
1,665

Similar funds

Covenant Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Covenant Partners held 150 positions worth $353M, up 5.3% from $335M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Covenant Partners's Q3 2025 filing shows 4 new, 17 increased, 12 reduced and 15 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 604 shares worth $275K. The largest sale was iShares Russell 2000 Value ETF, an estimated $1.62M.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 8.9% a quarter earlier, followed by Financials and Healthcare.

  • Covenant Partners's largest Q3 2025 buy was Alnylam Pharmaceuticals: 604 shares worth $275K.
  • Covenant Partners added most to iShares Russell 1000 Growth ETF in Q3 2025, an estimated $1.6M increase.
  • Covenant Partners's biggest Q3 2025 reduction was iShares Russell 2000 Value ETF, cutting an estimated $1.62M.
  • Covenant Partners fully exited UnitedHealth in Q3 2025, selling an estimated $679K.
  • Covenant Partners's ten largest holdings make up 75% of its $353M portfolio in Q3 2025.
  • Covenant Partners opened 4 new positions and closed 15 in Q3 2025.
  • Covenant Partners's portfolio value rose 5.3% quarter-over-quarter to $353M.

Based on Covenant Partners's 13F filing for Q3 2025, filed 24 Oct 2025.